Company registration number 12204373 (England and Wales)
PDC MEDICAL LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
PAGES FOR FILING WITH REGISTRAR
PDC MEDICAL LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
PDC MEDICAL LIMITED
BALANCE SHEET
AS AT
30 SEPTEMBER 2024
30 September 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
39,958
50,917
Current assets
Debtors
5
-
0
4,221
Cash at bank and in hand
59,954
9,937
59,954
14,158
Creditors: amounts falling due within one year
6
(61,748)
(26,188)
Net current liabilities
(1,794)
(12,030)
Total assets less current liabilities
38,164
38,887
Creditors: amounts falling due after more than one year
7
(30,181)
(40,382)
Net assets/(liabilities)
7,983
(1,495)
Capital and reserves
Called up share capital
400
400
Profit and loss reserves
7,583
(1,895)
Total equity
7,983
(1,495)

For the financial year ended 30 September 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 28 October 2025
Dr R Da Cunha
Director
Company registration number 12204373 (England and Wales)
PDC MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 2 -
1
Accounting policies
Company information

PDC Medical Limited is a private company limited by shares incorporated in England and Wales. The registered office is 1st Floor Gallery Court, 28 Arcadia Avenue, London, N3 2FG.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover represents the amounts receivable for services provided to clients.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
20% Straight line
Computers
25% Straight line
Motor vehicles
25% Reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Recoverable amount is the higher of fair value less costs to sell and value in use. In assessing value in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset for which the estimates of future cash flows have not been adjusted.

If the recoverable amount of an asset (or cash-generating unit) is estimated to be less than its carrying amount, the carrying amount of the asset (or cash-generating unit) is reduced to its recoverable amount. An impairment loss is recognised immediately in profit or loss, unless the relevant asset is carried at a revalued amount, in which case the impairment loss is treated as a revaluation decrease.

PDC MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
1
Accounting policies
(Continued)
- 3 -
1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors and bank loans are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

PDC MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
1
Accounting policies
(Continued)
- 4 -
1.9
Leases
As lessee

Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.

Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
0
0
PDC MEDICAL LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 30 SEPTEMBER 2024
- 5 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 October 2023
84,457
Additions
4,235
At 30 September 2024
88,692
Depreciation and impairment
At 1 October 2023
33,540
Depreciation charged in the year
15,194
At 30 September 2024
48,734
Carrying amount
At 30 September 2024
39,958
At 30 September 2023
50,917
5
Debtors
2024
2023
Amounts falling due within one year:
£
£
Other debtors
-
0
4,221
6
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans
4,652
4,945
Corporation tax
22,833
9,097
Other creditors
34,263
12,146
61,748
26,188
7
Creditors: amounts falling due after more than one year
2024
2023
£
£
Bank loans and overdrafts
7,403
12,473
Other creditors
22,778
27,909
30,181
40,382
2024-09-30 2023-10-01 false false false 28 October 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Mr R Da Cunha 12204373 2023-10-01 2024-09-30 12204373 2024-09-30 12204373 2023-09-30 12204373 core:OtherPropertyPlantEquipment 2024-09-30 12204373 core:OtherPropertyPlantEquipment 2023-09-30 12204373 core:ShareCapital 2024-09-30 12204373 core:ShareCapital 2023-09-30 12204373 core:RetainedEarningsAccumulatedLosses 2024-09-30 12204373 core:RetainedEarningsAccumulatedLosses 2023-09-30 12204373 bus:Director1 2023-10-01 2024-09-30 12204373 core:FurnitureFittings 2023-10-01 2024-09-30 12204373 core:ComputerEquipment 2023-10-01 2024-09-30 12204373 core:MotorVehicles 2023-10-01 2024-09-30 12204373 2022-10-01 2023-09-30 12204373 core:OtherPropertyPlantEquipment 2023-09-30 12204373 core:OtherPropertyPlantEquipment 2023-10-01 2024-09-30 12204373 core:WithinOneYear 2024-09-30 12204373 core:WithinOneYear 2023-09-30 12204373 core:CurrentFinancialInstruments 2024-09-30 12204373 core:CurrentFinancialInstruments 2023-09-30 12204373 core:Non-currentFinancialInstruments 2024-09-30 12204373 core:Non-currentFinancialInstruments 2023-09-30 12204373 bus:PrivateLimitedCompanyLtd 2023-10-01 2024-09-30 12204373 bus:SmallCompaniesRegimeForAccounts 2023-10-01 2024-09-30 12204373 bus:FRS102 2023-10-01 2024-09-30 12204373 bus:AuditExemptWithAccountantsReport 2023-10-01 2024-09-30 12204373 bus:FullAccounts 2023-10-01 2024-09-30 xbrli:pure xbrli:shares iso4217:GBP